RT Journal Article
SR Electronic
T1 Artificial intelligence strengthenes cervical cancer screening – present and future
JF Cancer Biology & Medicine
JO Cancer Biology & Medicine
FD China Anti-Cancer Association
SP 20240198
DO 10.20892/j.issn.2095-3941.2024.0198
A1 Wu, Tong
A1 Lucas, Eric
A1 Zhao, Fanghui
A1 Basu, Partha
A1 Qiao, Youlin
YR 2024
UL http://www.cancerbiomed.org/content/early/2024/09/19/j.issn.2095-3941.2024.0198.abstract
AB Cervical cancer is a severe threat to women’s health. The majority of cervical cancer cases occur in developing countries. The WHO has proposed screening 70% of women with high-performance tests between 35 and 45 years of age by 2030 to accelerate the elimination of cervical cancer. Due to an inadequate health infrastructure and organized screening strategy, most low- and middle-income countries are still far from achieving this goal. As part of the efforts to increase performance of cervical cancer screening, it is necessary to investigate the most accurate, efficient, and effective methods and strategies. Artificial intelligence (AI) is rapidly expanding its application in cancer screening and diagnosis and deep learning algorithms have offered human-like interpretation capabilities on various medical images. AI will soon have a more significant role in improving the implementation of cervical cancer screening, management, and follow-up. This review aims to report the state of AI with respect to cervical cancer screening. We discuss the primary AI applications and development of AI technology for image recognition applied to detection of abnormal cytology and cervical neoplastic diseases, as well as the challenges that we anticipate in the future.